Albert Friesen

Albert D.
Friesen is the founder of Viventia Biotech, Inc. (founded 1995), Medicure, Inc. (founded 1997) where the title held is Chairman, President & Chief Executive Officer, Luminor Medical Technologies, Inc. (founded 1998) where the title held is Chairman, Winnipeg RH Institute Foundation, Inc. (founded 1971) where the title held is President, and Genesys Venture, Inc. (founded 1997) where the title held is President.
Dr. Friesen is also the founder of ABI Biotechnology, Inc.,Genesys Pharma, Inc.,KAM Scientific, Inc.,Industrial Biotechnology Association of Canada..
Dr. Friesen is Chief Executive Officer at CentreStone Ventures, Inc. since 2006.
Dr. Friesen is Chairman, President & Chief Executive Officer at Marsala Biotech Inc. Dr. Friesen is Co-Chairman at Manitoba Innovation Council.
Dr. Friesen is Chairman at Waverley Pharma, Inc. since 2016.
Dr. Friesen is Chairman & President at GVI Clinical Development Solutions, Inc. Dr. Friesen is Director at Mylan API, Inc. Dr. Friesen is Director at Magellan Biotech, Inc. Dr. Friesen is Director at Canada Foundation for Innovation since 2010.
Dr. Friesen is Director at Sensible Medical Innovations Ltd. since 2019.
Dr. Friesen was Chief Executive Officer & Director at Big Sky Petroleum Corp.
from 2006 to 2008.
Dr. Friesen was CEO, Secretary & Non-Independent Director at Buffalo Capital, Inc. Dr. Friesen was Chairman at Kane Biotech, Inc. from 2001 to 2011.
Dr. Friesen was Director at DiaMedica Therapeutics, Inc. from 2007 to 2008.
Dr. Friesen was Director at MEDA Investments, Inc. from 2000 to 2012.
Dr. Friesen was Director at Waverley Pharma, Inc. Dr. Friesen was Member-Industrial Advisory Committee at Biotechnology Research Corp.
Dr. Friesen earned a doctorate from the University of Manitoba.